TipRanks
Advertisement
Advertisement

DE:2VF0 Stock Latest News

Hemostemix Advances $1 Million Private Placement to Fund Stem Cell Therapy Commercialization
Company AnnouncementsHemostemix Advances $1 Million Private Placement to Fund Stem Cell Therapy Commercialization
8d ago
Hemostemix Raises CDN$322,250 in Second Tranche of Private Placement
PremiumCompany Announcements
Hemostemix Raises CDN$322,250 in Second Tranche of Private Placement
2M ago
PremiumCompany Announcements
Hemostemix Raises $784,000 to Advance Stem Cell Therapy Commercialization
7M ago
Hemostemix Raises C$480,000 to Advance Stem Cell Therapy Commercialization
PremiumCompany Announcements
Hemostemix Raises C$480,000 to Advance Stem Cell Therapy Commercialization
9M ago
Hemostemix Grants Stock Options to Boost Growth
PremiumCompany Announcements
Hemostemix Grants Stock Options to Boost Growth
10M ago
Hemostemix Highlights VesCell Success at DFCon 2025 and Secures New Funding
PremiumCompany AnnouncementsHemostemix Highlights VesCell Success at DFCon 2025 and Secures New Funding
10M ago
Hemostemix Secures CDN$280,594 Private Placement for Operational Growth
Premium
Company Announcements
Hemostemix Secures CDN$280,594 Private Placement for Operational Growth
11M ago
Hemostemix Closes $461,230 Private Placement to Boost Operations
Premium
Company Announcements
Hemostemix Closes $461,230 Private Placement to Boost Operations
11M ago
Hemostemix Secures TSXV Approval for Debt Settlement
PremiumCompany Announcements
Hemostemix Secures TSXV Approval for Debt Settlement
1y ago
Hemostemix Announces Strategic Private Placement to Enhance Operations
PremiumCompany Announcements
Hemostemix Announces Strategic Private Placement to Enhance Operations
1y ago
Hemostemix Expands Private Placement to $3 Million
PremiumCompany Announcements
Hemostemix Expands Private Placement to $3 Million
1y ago
Hemostemix Advances with Successful Sale of Convertible Debentures
PremiumCompany Announcements
Hemostemix Advances with Successful Sale of Convertible Debentures
1y ago
Hemostemix Secures $2.97 Million in Private Placement to Boost Operations
PremiumCompany AnnouncementsHemostemix Secures $2.97 Million in Private Placement to Boost Operations
1y ago
Hemostemix Closes Oversubscribed Private Placement and Settles Debt
Premium
Company Announcements
Hemostemix Closes Oversubscribed Private Placement and Settles Debt
1y ago
Hemostemix Secures $1.5 Million Lead Order and Repays Convertible Debenture
Premium
Company Announcements
Hemostemix Secures $1.5 Million Lead Order and Repays Convertible Debenture
1y ago
Hemostemix Secures $336,500 in Private Placement to Bolster Growth
PremiumCompany Announcements
Hemostemix Secures $336,500 in Private Placement to Bolster Growth
1y ago
Hemostemix Raises $2.67M to Boost Stem Cell Research
PremiumCompany Announcements
Hemostemix Raises $2.67M to Boost Stem Cell Research
2y ago
Hemostemix Secures $1.8M in Private Placement
PremiumCompany Announcements
Hemostemix Secures $1.8M in Private Placement
2y ago
Hemostemix Launches $4M Financing for Stem Cell Therapy Growth
PremiumCompany Announcements
Hemostemix Launches $4M Financing for Stem Cell Therapy Growth
2y ago
Hemostemix Partners with CytoImmune, Boosts ACP-01 Production
PremiumCompany AnnouncementsHemostemix Partners with CytoImmune, Boosts ACP-01 Production
2y ago
Hemostemix Accelerates Cell Therapy Production with CytoImmune
Premium
Company Announcements
Hemostemix Accelerates Cell Therapy Production with CytoImmune
2y ago
Hemostemix Partners with OHAM for Strategic Fundraising
Premium
Company Announcements
Hemostemix Partners with OHAM for Strategic Fundraising
3y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >